Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
24 03 2020
Historique:
received: 11 12 2019
accepted: 23 03 2020
pubmed: 25 3 2020
medline: 30 3 2021
entrez: 25 3 2020
Statut: epublish

Résumé

By sequencing autozygous human populations, we identified a healthy adult woman with lifelong complete knockout of

Identifiants

pubmed: 32207686
doi: 10.7554/eLife.54363
pii: 54363
pmc: PMC7108859
doi:
pii:

Substances chimiques

Glycolates 0
glycolic acid 0WT12SX38S
Alcohol Oxidoreductases EC 1.1.-
HAO1 protein, human EC 1.1.3.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom
Organisme : Wellcome
ID : WT210561
Organisme : Medical Research Council
ID : M009017
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024397/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome
ID : WT102627

Informations de copyright

© 2020, McGregor et al.

Déclaration de conflit d'intérêts

TM, EY, PN, ST, MP, DE employee of Alnylam Pharmaceuticals, KH, DM, PL, SF, DL, QH, CG, DM, RT, DO, JL, JW, Dv No competing interests declared, EF is affiliated with Pfizer Worldwide Research. The author has no financial interests to declare. Contributed as an individual and the work was not part of a Pfizer collaboration nor was it funded by Pfizer.

Références

J Am Soc Nephrol. 2017 Feb;28(2):494-503
pubmed: 27432743
Am J Hum Genet. 2006 Sep;79(3):514-23
pubmed: 16909389
Mol Ther. 2016 Apr;24(4):719-25
pubmed: 26689264
Clin Chem. 1991 Jul;37(7):1229-35
pubmed: 1855295
Nat Commun. 2019 Apr 5;10(1):1579
pubmed: 30952858
PLoS Genet. 2014 Jul 31;10(7):e1004494
pubmed: 25078778
N Engl J Med. 2017 Jan 5;376(1):41-51
pubmed: 27959715
Science. 2016 Apr 22;352(6284):474-7
pubmed: 26940866
J Med Genet. 2014 Aug;51(8):526-9
pubmed: 24996905
Pediatr Nephrol. 2017 Nov;32(11):2159-2163
pubmed: 28752386
Int J Epidemiol. 2019 Aug 28;:
pubmed: 31504546
Mol Ther. 2016 Apr;24(4):770-8
pubmed: 26758691
Nature. 2017 Apr 12;544(7649):235-239
pubmed: 28406212
Nat Rev Drug Discov. 2017 Jul 31;16(8):515-518
pubmed: 28757624
J Cell Sci. 2001 May;114(Pt 9):1625-9
pubmed: 11309194
N Engl J Med. 2013 Aug 15;369(7):649-58
pubmed: 23944302
J Inherit Metab Dis. 1996;19(6):793-4
pubmed: 8982955
Nat Commun. 2018 Feb 19;9(1):711
pubmed: 29459775

Auteurs

Tracy L McGregor (TL)

Alnylam Pharmaceuticals, Cambridge, United States.

Karen A Hunt (KA)

Blizard Institute and Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Elaine Yee (E)

Alnylam Pharmaceuticals, Cambridge, United States.

Dan Mason (D)

Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford, United Kingdom.

Paul Nioi (P)

Alnylam Pharmaceuticals, Cambridge, United States.

Simina Ticau (S)

Alnylam Pharmaceuticals, Cambridge, United States.

Marissa Pelosi (M)

Alnylam Pharmaceuticals, Cambridge, United States.

Perry R Loken (PR)

Mayo Clinic, Division of Nephrology and Hypertension, Rochester, United States.

Sarah Finer (S)

Blizard Institute and Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Deborah A Lawlor (DA)

MRC Integrative Epidemiology Unit at the University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom.
Population Health Science, Bristol Medical School, Bristol University, Bristol, United Kingdom.
Bristol NIHR Biomedical Research Centre, Bristol, United Kingdom.

Eric B Fauman (EB)

Internal Medicine Research Unit, Pfizer Worldwide Research, Development and Medical, Cambridge, United States.

Qin Qin Huang (QQ)

Wellcome Sanger Institute, Hinxton, United Kingdom.

Christopher J Griffiths (CJ)

Blizard Institute and Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Daniel G MacArthur (DG)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, United States.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, United States.

Richard C Trembath (RC)

School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

Devin Oglesbee (D)

Mayo Clinic, Division of Nephrology and Hypertension, Rochester, United States.

John C Lieske (JC)

Mayo Clinic, Division of Nephrology and Hypertension, Rochester, United States.

David V Erbe (DV)

Alnylam Pharmaceuticals, Cambridge, United States.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford, United Kingdom.

David A van Heel (DA)

Blizard Institute and Institute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH